Functional Brands, Inc. Common Stock
MEHA
Get informed when a big investor buys or sells
+ FollowMarket Cap$251.14M
Close$
Share Statistics
| Market cap | $251.14 Million |
|---|---|
| Enterprise Value | $199.22 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -34.10% |
|---|---|
| Return on Assets | -31.35% |
| Return on Invested Capital | -35.52% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 19.92 |
| Enterprise Value to EBIT | -1.97 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Evommune, Inc.
45 employees
CEO: Luis C. Pena Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. It develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic sponta...